A call to protect the health care workers fighting COVID-19 in the United States

Alexander W. Charney; Craig Katz; Steven M. Southwick; Dennis S. Charney

doi:10.1176/appi.ajp.2020.20040535

A call to protect the health care workers fighting COVID-19 in the United States

Alexander W. Charney, Craig Katz, Steven M. Southwick, Dennis S. Charney

Research output: Contribution to journal › Comment/debate

11 Scopus citations

Original language	English
Pages (from-to)	900-901
Number of pages	2
Journal	American Journal of Psychiatry
Volume	177
Issue number	10
DOIs	https://doi.org/10.1176/appi.ajp.2020.20040535
State	Published - Oct 2020

Access to Document

10.1176/appi.ajp.2020.20040535

Cite this

@article{a5cae91b8cc54c2e8df9a2e801d1eb40,

title = "A call to protect the health care workers fighting COVID-19 in the United States",

author = "Charney, {Alexander W.} and Craig Katz and Southwick, {Steven M.} and Charney, {Dennis S.}",

note = "Funding Information: Dr. Dennis Charney is named as a coinventor on patents filed by the Icahn SchoolofMedicineatMountSinairelatedtotreatmentoftreatment-resistant depression, suicidal ideation, and other disorders; to a cognitive training intervention to treat depression and related psychiatric disorders; to the use of intranasally administered neuropeptide Y for the treatment of mood and anxiety disorders; and to the use of ketamine for the treatment of posttraumatic stress disorder. The Icahn School of Medicine has entered into licensing agreements with Click Therapeutics and Janssen and has received and will receive payments from these companies under the agreements related to some of these patents, under which Dr. Charney may also receive payments. Dr. Charney also receives research funding from the Brain and Behavior Research Foundation and the National Heart, Lung, and Blood Institute. Dr. Katz has served as a consultant to Advanced Recovery Systems. Dr. Southwick receives royalties from Cambridge University Press. Dr. Alexander Charney reports no financial relationships with commercial interests.",

year = "2020",

month = oct,

doi = "10.1176/appi.ajp.2020.20040535",

language = "English",

volume = "177",

pages = "900--901",

journal = "American Journal of Psychiatry",

issn = "0002-953X",

publisher = "American Psychiatric Association",

number = "10",

}

TY - JOUR

T1 - A call to protect the health care workers fighting COVID-19 in the United States

AU - Charney, Alexander W.

AU - Katz, Craig

AU - Southwick, Steven M.

AU - Charney, Dennis S.

N1 - Funding Information: Dr. Dennis Charney is named as a coinventor on patents filed by the Icahn SchoolofMedicineatMountSinairelatedtotreatmentoftreatment-resistant depression, suicidal ideation, and other disorders; to a cognitive training intervention to treat depression and related psychiatric disorders; to the use of intranasally administered neuropeptide Y for the treatment of mood and anxiety disorders; and to the use of ketamine for the treatment of posttraumatic stress disorder. The Icahn School of Medicine has entered into licensing agreements with Click Therapeutics and Janssen and has received and will receive payments from these companies under the agreements related to some of these patents, under which Dr. Charney may also receive payments. Dr. Charney also receives research funding from the Brain and Behavior Research Foundation and the National Heart, Lung, and Blood Institute. Dr. Katz has served as a consultant to Advanced Recovery Systems. Dr. Southwick receives royalties from Cambridge University Press. Dr. Alexander Charney reports no financial relationships with commercial interests.

PY - 2020/10

Y1 - 2020/10

UR - http://www.scopus.com/inward/record.url?scp=85089795536&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.2020.20040535

DO - 10.1176/appi.ajp.2020.20040535

M3 - Comment/debate

C2 - 32731814

AN - SCOPUS:85089795536

SN - 0002-953X

VL - 177

SP - 900

EP - 901

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

IS - 10

ER -